Predictive methylation signature for gemcitabine sensitivity in pancreatic ductal adenocarcinoma: A pathway to personalized treatment.

被引：0
作者：
Sherpally, Deepak
Jeepalyam, Sravan
Puram, Harshitha
Manne, Ashish
机构：
[1] Metropolitan Hosp Ctr, New York, NY USA
[2] Stormont Vail Hlth, Topeka, KS USA
[3] Univ Cincinnati, Cincinnati, OH USA
[4] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.768
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：768 / 768
页数：1
相关论文
共 50 条
[41]   Neoadjuvant treatment of pancreatic ductal adenocarcinoma [J].
Kosma, Katharina ;
Thalhammer, Sabine ;
Gruenberger, Thomas .
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (03) :219-223
[42]   Surgical Treatment of Pancreatic Ductal Adenocarcinoma [J].
Wei, Kongyuan ;
Hackert, Thilo .
CANCERS, 2021, 13 (08)
[43]   The personalized medicine for pancreatic ductal adenocarcinoma patients: The oncologist perspective [J].
Peretti, Umberto ;
Zanon, Silvia ;
Michele, Reni .
ENDOSCOPIC ULTRASOUND, 2017, 6 :S66-S68
[44]   The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities [J].
Tesfaye, Anteneh A. ;
Kamgar, Mandana ;
Azmi, Asfar ;
Philip, Philip A. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (02) :131-148
[45]   Combination of gemcitabine and cytidine deaminase inhibitor: A breakthrough cocktail for the treatment of pancreatic ductal adenocarcinoma. [J].
Patki, Manali ;
Saraswat, Aishwarya ;
Bhutkar, Shraddha ;
Dukhande, Vikas ;
Patel, Ketankumar .
CANCER RESEARCH, 2021, 81 (13)
[46]   Preclinical treatment of pancreatic ductal adenocarcinoma using targetable self-assembled gemcitabine nanoparticles [J].
Fu, Zhang .
CANCER RESEARCH, 2020, 80 (16)
[47]   Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers [J].
Taherian, Mehran ;
Wang, Hua ;
Wang, Huamin .
CELLS, 2022, 11 (19)
[48]   Signature protein biomarkers in serum for diagnosis of pancreatic ductal adenocarcinoma [J].
Lindgaard, S. C. ;
Maag, E. ;
Chen, I. ;
Johansen, A. Z. ;
Hansen, C. P. ;
Hasselby, J. P. ;
Jensen, B. V. ;
Bojesen, S. E. ;
Nielsen, K. R. ;
Nielsen, D. L. ;
Johansen, J. S. .
ANNALS OF ONCOLOGY, 2020, 31 :S945-S945
[49]   Pancreatic Ductal Adenocarcinoma is Associated with a Distinct Urinary Metabolomic Signature [J].
Davis, Vanessa W. ;
Schiller, Daniel E. ;
Eurich, Dean ;
Bathe, Oliver F. ;
Sawyer, Michael B. .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 :S415-S423
[50]   A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma [J].
Sahni, Sumit ;
Pandya, Advait R. ;
Hadden, William J. ;
Nahm, Christopher B. ;
Maloney, Sarah ;
Cook, Victoria ;
Toft, James A. ;
Wilkinson-White, Lorna ;
Gill, Anthony J. ;
Samra, Jaswinder S. ;
Dona, Anthony ;
Mittal, Anubhav .
INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (06) :1508-1518
12345